Ignite Creation Date:
2025-12-24 @ 6:37 PM
Ignite Modification Date:
2026-01-02 @ 1:33 PM
Study NCT ID:
NCT00544557
Status:
COMPLETED
Last Update Posted:
2015-05-12
First Post:
2007-10-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis
Sponsor:
Pfizer
Organization:
Study Overview
Official Title:
Observational Study Of The Use Of Enbrel (Registered) (Etanercept) In Routine Clinical Practice To Treat Ankylosing Spondylitis (as) Patients: An Effectiveness, Safety, And Health Economic Evaluation
Status:
COMPLETED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to provide a holistic assessment of patients receiving etanercept in a real-world setting.
Detailed Description:
Non-interventional study: subjects to be selected according to the usual clinical practice of their physician
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| B1801087 | OTHER | Alias Study Number | View |